SU1218919A3 - Способ получени цефалексина продленного действи дл перорального применени - Google Patents

Способ получени цефалексина продленного действи дл перорального применени Download PDF

Info

Publication number
SU1218919A3
SU1218919A3 SU772485596A SU2485596A SU1218919A3 SU 1218919 A3 SU1218919 A3 SU 1218919A3 SU 772485596 A SU772485596 A SU 772485596A SU 2485596 A SU2485596 A SU 2485596A SU 1218919 A3 SU1218919 A3 SU 1218919A3
Authority
SU
USSR - Soviet Union
Prior art keywords
cefalexin
coated
preparation
normal
cephalexin
Prior art date
Application number
SU772485596A
Other languages
English (en)
Russian (ru)
Inventor
Маекава Хидеюки
Такагиси Ясуси
Като Хироси
Original Assignee
Сионоги Энд Ко,Лтд (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сионоги Энд Ко,Лтд (Фирма) filed Critical Сионоги Энд Ко,Лтд (Фирма)
Application granted granted Critical
Publication of SU1218919A3 publication Critical patent/SU1218919A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
SU772485596A 1976-05-13 1977-05-12 Способ получени цефалексина продленного действи дл перорального применени SU1218919A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (1)

Publication Number Publication Date
SU1218919A3 true SU1218919A3 (ru) 1986-03-15

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772485596A SU1218919A3 (ru) 1976-05-13 1977-05-12 Способ получени цефалексина продленного действи дл перорального применени

Country Status (27)

Country Link
JP (1) JPS52139713A (nl)
AR (1) AR224494A1 (nl)
AT (1) AT351159B (nl)
AU (1) AU508793B2 (nl)
BE (1) BE854640A (nl)
CA (1) CA1085296A (nl)
CS (1) CS208196B2 (nl)
DD (1) DD132232A5 (nl)
DE (1) DE2721785A1 (nl)
DK (1) DK208077A (nl)
ES (1) ES458710A1 (nl)
FI (1) FI771491A (nl)
FR (1) FR2350836A1 (nl)
GB (1) GB1543543A (nl)
GR (1) GR68895B (nl)
HU (1) HU184196B (nl)
IE (1) IE45415B1 (nl)
IL (1) IL52075A (nl)
MX (1) MX5976E (nl)
NL (1) NL7704879A (nl)
NZ (1) NZ183927A (nl)
PL (1) PL111183B1 (nl)
PT (1) PT66514B (nl)
RO (1) RO72935A (nl)
SE (1) SE426780B (nl)
SU (1) SU1218919A3 (nl)
ZA (1) ZA772757B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
За вка DE № 2325410, кл. 12 С 3/00, .1974. *

Also Published As

Publication number Publication date
CS208196B2 (en) 1981-08-31
IL52075A (en) 1980-06-30
AU2507877A (en) 1978-11-16
PT66514B (en) 1978-10-16
FI771491A (nl) 1977-11-14
JPS5547611B2 (nl) 1980-12-01
DE2721785A1 (de) 1977-11-24
AU508793B2 (en) 1980-04-03
GB1543543A (en) 1979-04-04
PL198058A1 (pl) 1979-03-26
BE854640A (fr) 1977-09-01
IL52075A0 (en) 1977-07-31
ES458710A1 (es) 1978-03-01
SE7705502L (sv) 1977-11-14
IE45415L (en) 1977-11-13
MX5976E (es) 1984-09-12
IE45415B1 (en) 1982-08-25
RO72935A (ro) 1982-07-06
PT66514A (en) 1977-06-01
JPS52139713A (en) 1977-11-21
SE426780B (sv) 1983-02-14
AR224494A1 (es) 1981-12-15
DE2721785C2 (nl) 1989-03-16
CA1085296A (en) 1980-09-09
NL7704879A (nl) 1977-11-15
HU184196B (en) 1984-07-30
ATA341877A (de) 1978-12-15
AT351159B (de) 1979-07-10
DK208077A (da) 1977-11-14
FR2350836B1 (nl) 1981-02-06
NZ183927A (en) 1980-02-21
GR68895B (nl) 1982-03-15
FR2350836A1 (fr) 1977-12-09
PL111183B1 (en) 1980-08-30
ZA772757B (en) 1978-04-26
DD132232A5 (de) 1978-09-13

Similar Documents

Publication Publication Date Title
US3492397A (en) Sustained release dosage in the pellet form and process thereof
US4684516A (en) Sustained release tablets and method of making same
RU2240786C2 (ru) Пероральные лекарственные формы пролонгированного действия
US5529790A (en) Delayed, sustained-release diltiazem pharmaceutical preparation
US5496561A (en) Controlled release-initiation and controlled release-rate pharmaceutical composition
AU781058B2 (en) Delayed-action form of administration containing tramadol saccharinate
AU592363B2 (en) Controlled release tablet
US5552152A (en) Taste masking of ibuprofen by fluid bed coating
KR880001753B1 (ko) 브롬헥신 서방출성 제형의 제조방법
SU1218919A3 (ru) Способ получени цефалексина продленного действи дл перорального применени
JPH0772130B2 (ja) 持続性製剤
JPH02202A (ja) 徐放性医薬製剤
WO2001058433A1 (en) Timed pulsatile drug delivery systems
JPH04234313A (ja) 徐放性組成物
PL175326B1 (pl) Preparat doustny wielojednostkowy o kontrolowanym uwalnianiu zawierający morfinę i sposób wytwarzania preparatu doustnego wielojednostkowego o kontrolowanym uwalnianiu zawierającego morfinę
DK158032B (da) Polydepotpraeparat med kontrolleret afgivelse af aktivt stof og fremgangsmaade til fremstilling af dette polydepotpraeparat
JPH0733330B2 (ja) 弾性被膜を有する安定な固形調剤及びその製造方法
JPS6261916A (ja) 持続性製剤
WO2001087269A1 (en) A coating composition for facilitating controlled release
GB2190287A (en) Oral ketoprofen formulation
CN1232386A (zh) 弱酸药物的结肠运送
JP2528652B2 (ja) 持効性セフラジン製剤
RU2292877C2 (ru) Лекарственная ретард-форма, содержащая сахаринат трамадола
KR840000692B1 (ko) 디피리다몰 서방출형 제제의 제조방법
JPH09175998A (ja) 粉末コーティングされた固形製剤